|
Volumn 89, Issue 9, 1997, Pages 3490-3491
|
Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders.
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
LYMPHOCYTE ANTIGEN RECEPTOR;
PREDNISOLONE;
VAP CYCLO PROTOCOL;
VAP-CYCLO PROTOCOL;
VINCRISTINE;
CHROMOSOME 7;
CYTOTOXIC T LYMPHOCYTE;
GENETICS;
HUMAN;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
LIVER TUMOR;
NOTE;
PATHOLOGY;
POSTOPERATIVE COMPLICATION;
SPLEEN TUMOR;
T CELL LYMPHOMA;
T LYMPHOCYTE SUBPOPULATION;
TRISOMY;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOSOMES, HUMAN, PAIR 7;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVER NEOPLASMS;
LYMPHOMA, T-CELL;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;
RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;
SPLENIC NEOPLASMS;
T-LYMPHOCYTE SUBSETS;
T-LYMPHOCYTES, CYTOTOXIC;
TRISOMY;
VINCRISTINE;
MLCS;
MLOWN;
|
EID: 0031136671
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood.v89.9.3490 Document Type: Note |
Times cited : (17)
|
References (0)
|